Connor, Clark & Lunn Investment Management Ltd. Mannkind Corp Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $21.8 Billion
- Q1 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Mannkind Corp stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 1,088,802 shares of MNKD stock, worth $5.68 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,088,802
Previous 752,824
44.63%
Holding current value
$5.68 Million
Previous $2.74 Million
80.0%
% of portfolio
0.02%
Previous 0.01%
Shares
6 transactions
Others Institutions Holding MNKD
# of Institutions
209Shares Held
130MCall Options Held
1.81MPut Options Held
808K-
Black Rock Inc. New York, NY21.6MShares$113 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$79 Million0.0% of portfolio
-
State Street Corp Boston, MA11.9MShares$62.3 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY10.1MShares$52.6 Million4.85% of portfolio
-
Avoro Capital Advisors LLC New York, NY9MShares$47 Million0.49% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.34B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...